Fjord-Edge Graphene Nanoribbons with Site-Specific Nitrogen Substitution
摘要:
The synthesis of graphene nanoribbons (GNRs) that contain site-specifically substituted backbone heteroatoms is one of the essential goals that must be achieved in order to control the electronic properties of these next generation organic materials. We have exploited our recently reported solid-state topochemical polymerization/cyclization-aromatization strategy to convert the simple 1,4-bis(3-pyridyl)butadiynes 3a,b into the fjord-edge nitrogen-doped graphene nanoribbon structures 1a,b (fjord-edge N-2[8]GNRs). Structural assignments are confirmed by CP/MAS C-13 NMR, Raman, and XPS spectroscopy. The fjord-edge N2[8]GNRs 1a,b are promising precursors for the novel backbone nitrogen-substituted N-2[8](A)GNRs 2a,b. Geometry and band calculations on N-2[8](A)GNR 2c indicate that this class of nanoribbons should have unusual bonding topology and metallicity.
Fjord-Edge Graphene Nanoribbons with Site-Specific Nitrogen Substitution
摘要:
The synthesis of graphene nanoribbons (GNRs) that contain site-specifically substituted backbone heteroatoms is one of the essential goals that must be achieved in order to control the electronic properties of these next generation organic materials. We have exploited our recently reported solid-state topochemical polymerization/cyclization-aromatization strategy to convert the simple 1,4-bis(3-pyridyl)butadiynes 3a,b into the fjord-edge nitrogen-doped graphene nanoribbon structures 1a,b (fjord-edge N-2[8]GNRs). Structural assignments are confirmed by CP/MAS C-13 NMR, Raman, and XPS spectroscopy. The fjord-edge N2[8]GNRs 1a,b are promising precursors for the novel backbone nitrogen-substituted N-2[8](A)GNRs 2a,b. Geometry and band calculations on N-2[8](A)GNR 2c indicate that this class of nanoribbons should have unusual bonding topology and metallicity.
FUSED RING COMPOUND CONTAINING FURAN OR SALT THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
申请人:YUHAN CORPORATION
公开号:US20150191478A1
公开(公告)日:2015-07-09
The present invention provides a fused ring compound containing furan or a pharmaceutically acceptable salt thereof, a method for preparing same, a pharmaceutical composition comprising same, and a use thereof. The fused ring compound containing furan or a pharmaceutically acceptable salt thereof inhibits the activity of phosphatidylinositol 3-kinase (PI3K) and can therefore be used in a pharmaceutical composition for treating and preventing respiratory diseases, inflammatory diseases, proliferative diseases, cardiovascular diseases, or central nervous system diseases which occur due to the over-activation of PI3K.
Fjord-Edge Graphene Nanoribbons with Site-Specific Nitrogen Substitution
作者:Yolanda L. Li、Chih-Te Zee、Janice B. Lin、Victoria M. Basile、Mit Muni、Maria D. Flores、Julen Munárriz、Richard B. Kaner、Anastassia N. Alexandrova、K. N. Houk、Sarah H. Tolbert、Yves Rubin
DOI:10.1021/jacs.0c07657
日期:2020.10.21
The synthesis of graphene nanoribbons (GNRs) that contain site-specifically substituted backbone heteroatoms is one of the essential goals that must be achieved in order to control the electronic properties of these next generation organic materials. We have exploited our recently reported solid-state topochemical polymerization/cyclization-aromatization strategy to convert the simple 1,4-bis(3-pyridyl)butadiynes 3a,b into the fjord-edge nitrogen-doped graphene nanoribbon structures 1a,b (fjord-edge N-2[8]GNRs). Structural assignments are confirmed by CP/MAS C-13 NMR, Raman, and XPS spectroscopy. The fjord-edge N2[8]GNRs 1a,b are promising precursors for the novel backbone nitrogen-substituted N-2[8](A)GNRs 2a,b. Geometry and band calculations on N-2[8](A)GNR 2c indicate that this class of nanoribbons should have unusual bonding topology and metallicity.